Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mogul Enterprises is a medical device research and development company specializing in innovative and affordable cardiovascular solutions. Founded in 1997 and headquartered in San Jose, California, the company focuses on electrophysiology (EP) diagnostic and therapeutic catheters, as well as multi-energy medical instrumentation for minimally invasive surgery. Its product portfolio includes the SlenderCath, Apica, and Aura lines of steerable and fixed-curve catheters, which have received FDA 510(k) clearance for cardiac mapping and stimulation. Mogul Enterprises also develops advanced technologies for ablation therapy, heart pumps, and vascular stents, often leveraging its intellectual property through licensing agreements with manufacturing partners like Tyche MedTech. The company's mission is to provide high-quality, cost-effective medical tools to budget-constrained hospitals and physicians globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mogul Enterprises.